Cargando…

Coronavirus disease 2019 (COVID-19): current status and future perspectives

Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [previously provisionally known as 2019 no...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Heng, Liu, Shang-Ming, Yu, Xiao-Hua, Tang, Shi-Lin, Tang, Chao-Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139247/
https://www.ncbi.nlm.nih.gov/pubmed/32234466
http://dx.doi.org/10.1016/j.ijantimicag.2020.105951
_version_ 1783518722614362112
author Li, Heng
Liu, Shang-Ming
Yu, Xiao-Hua
Tang, Shi-Lin
Tang, Chao-Ke
author_facet Li, Heng
Liu, Shang-Ming
Yu, Xiao-Hua
Tang, Shi-Lin
Tang, Chao-Ke
author_sort Li, Heng
collection PubMed
description Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [previously provisionally known as 2019 novel coronavirus (2019-nCoV)]. At present, the newly identified SARS-CoV-2 has caused a large number of deaths with tens of thousands of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19. Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies. Hence, this review will focus on recent progress regarding the structure of SARS-CoV-2 and the characteristics of COVID-19, such as the aetiology, pathogenesis and epidemiological characteristics.
format Online
Article
Text
id pubmed-7139247
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V. and International Society of Chemotherapy.
record_format MEDLINE/PubMed
spelling pubmed-71392472020-04-08 Coronavirus disease 2019 (COVID-19): current status and future perspectives Li, Heng Liu, Shang-Ming Yu, Xiao-Hua Tang, Shi-Lin Tang, Chao-Ke Int J Antimicrob Agents Article Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [previously provisionally known as 2019 novel coronavirus (2019-nCoV)]. At present, the newly identified SARS-CoV-2 has caused a large number of deaths with tens of thousands of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19. Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies. Hence, this review will focus on recent progress regarding the structure of SARS-CoV-2 and the characteristics of COVID-19, such as the aetiology, pathogenesis and epidemiological characteristics. Elsevier B.V. and International Society of Chemotherapy. 2020-05 2020-03-29 /pmc/articles/PMC7139247/ /pubmed/32234466 http://dx.doi.org/10.1016/j.ijantimicag.2020.105951 Text en © 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Li, Heng
Liu, Shang-Ming
Yu, Xiao-Hua
Tang, Shi-Lin
Tang, Chao-Ke
Coronavirus disease 2019 (COVID-19): current status and future perspectives
title Coronavirus disease 2019 (COVID-19): current status and future perspectives
title_full Coronavirus disease 2019 (COVID-19): current status and future perspectives
title_fullStr Coronavirus disease 2019 (COVID-19): current status and future perspectives
title_full_unstemmed Coronavirus disease 2019 (COVID-19): current status and future perspectives
title_short Coronavirus disease 2019 (COVID-19): current status and future perspectives
title_sort coronavirus disease 2019 (covid-19): current status and future perspectives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139247/
https://www.ncbi.nlm.nih.gov/pubmed/32234466
http://dx.doi.org/10.1016/j.ijantimicag.2020.105951
work_keys_str_mv AT liheng coronavirusdisease2019covid19currentstatusandfutureperspectives
AT liushangming coronavirusdisease2019covid19currentstatusandfutureperspectives
AT yuxiaohua coronavirusdisease2019covid19currentstatusandfutureperspectives
AT tangshilin coronavirusdisease2019covid19currentstatusandfutureperspectives
AT tangchaoke coronavirusdisease2019covid19currentstatusandfutureperspectives